The location of unilateral axillary lymphadenopathy after COVID-19 vaccination compared with that of metastasis from breast cancer without vaccination
Authors:
Open Access
- 10 January 2023
- journal article
- research article
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 41 (6) , 617-624
Abstract
Purpose: Unilateral axillary lymphadenopathy is known to occur after coronavirus disease (COVID-19) vaccination. Post-vaccination lymphadenopathy may mimic the metastatic lymph nodes in breast cancer, and it is challenging to distinguish between them. This study investigated whether the localization of axillary lymphadenopathy on magnetic resonance imaging (MRI) could be used to distinguish reactive lymphadenopathy after COVID-19 vaccines from metastatic nodes. Materials and methods: We retrospectively examined preoperative MRI images of 684 axillae in 342 patients who underwent breast cancer surgery from June to October 2021. Lymphadenopathy was defined as cortical thickening or short axis ≥ 5 mm. The axilla was divided into ventral and dorsal parts on the axial plane using a perpendicular line extending from the most anterior margin of the muscle group, including the deltoid, latissimus dorsi, or teres major muscles, relative to a line along the lateral chest wall. We recorded the presence or absence of axillary lymphadenopathy in each area and the number of visible lymph nodes. Results: Of 80 axillae, 41 and 39 were included in the vaccine and metastasis groups, respectively. The median time from the last vaccination to MRI was 19 days in the vaccine group. The number of visible axillary lymph nodes was significantly higher in the vaccine group (median, 15 nodes) than in the metastasis group (7 nodes) (P < 0.001). Dorsal lymphadenopathy was observed in 16 (39.0%) and two (5.1%) axillae in the vaccine and metastasis groups, respectively (P < 0.001). If the presence of both ventral and dorsal lymphadenopathy is considered indicative of vaccine-induced reaction, this finding has a sensitivity of 34.1%, specificity of 97.4%, and positive and negative predictive values of 93.3% and 58.5%, respectively. Conclusion: The presence of deep axillary lymphadenopathy may be an important factor for distinguishing post-vaccination lymphadenopathy from metastasis. The number of axillary lymph nodes may also help.Keywords
This publication has 26 references indexed in Scilit:
- COVID-19 Vaccination–Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 WomenAmerican Journal of Roentgenology, 2021
- Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic ApproachAmerican Journal of Roentgenology, 2021
- Axillary Nodal Evaluation in Breast Cancer: State of the ArtRadiology, 2020
- Deep lymphatic anatomy of the upper limb: An anatomical study and clinical implicationsAnnals of Anatomy - Anatomischer Anzeiger, 2019
- Axillary Sentinel Lymph Nodes in Breast Cancer: Quantitative Evaluation at Dual-Energy CTRadiology, 2018
- Axillary reverse mapping in axillary surgery for breast cancer: an update of the current statusBreast Cancer Research and Treatment, 2016
- Axillary Staging of Breast Cancer: What the Radiologist Should KnowRadioGraphics, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- New anatomical classification of the axilla with implications for sentinel node biopsyBritish Journal of Surgery, 2010
- Breast MRI: guidelines from the European Society of Breast ImagingEuropean Radiology, 2008